RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc.（RGRX）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · RGRX · 截至 Jun 9, 2026
关键指标
探索 RegeneRx Biopharmaceuticals, Inc. 数据
rgrx stock data · financials分析师评级与目标价
完整预测合计: 1 · 买入占比: 100.0%
竞争对手与同行
rgrx competitorsRGRX
BSYI
CHNXF
DRWN
FFNTF
FORZ关于 RegeneRx Biopharmaceuticals, Inc.
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and r…
what is regenerx biopharmaceuticals, inc. · rgrx stock overview · regenerx biopharmaceuticals, inc. company profile · who is regenerx biopharmaceuticals, inc. ceo · rgrx OTC · regenerx biopharmaceuticals, inc. headquarters · regenerx biopharmaceuticals, inc. business segments
关于股票概览与关键数据
RegeneRx Biopharmaceuticals, Inc.（RGRX）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 7, 2003 在 OTC 上市。截至最近交易日，RGRX 股价为 $0.00，市值约为 $898。过去12个月累计回报 —，年初至今回报 —。
常见问题
截至最近一个交易日，RegeneRx Biopharmaceuticals, Inc.（RGRX）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.16。